PRELUDE CAPITAL MANAGEMENT, LLC

Position in IONS — Ionis Pharmaceuticals Inc

CIK 1387508 NEW YORK, NY

Position in IONS

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$2,227,019

-$342,552 QoQ

Shares Held

29,658

-8.7% QoQ

Ownership

0.018%

of shares outstanding

% of Portfolio

0.21%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2020

10 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Mar 31, 2026

PRELUDE CAPITAL MANAGEMENT, LLC holds $45,146,517 across 96 Biotechnology names. IONS ranks #5 (4.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	PGEN	Precigen, Inc.	1,270,053	$4,915,105
2	ROIV	Roivant Sciences Ltd.	111,593	$3,091,126
3	PRAX	Praxis Precision Medicines, Inc.	9,064	$2,920,330
4	COGT	Cogent Biosciences, Inc.	64,222	$2,471,904
5	IONS	Ionis Pharmaceuticals Inc This page	29,658	$2,227,019
6	ELVN	Enliven Therapeutics, Inc.	52,578	$2,061,057
7	RVMD	Revolution Medicines, Inc.	17,073	$1,660,349
8	ALMS	Alumis Inc.	74,758	$1,646,918

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$2,227,019	29,658	-8.7%	Shares	Other	2026-05-15
2025-12-31	$2,569,571	32,481	-12.9%	Shares	Other	2026-02-17
2025-09-30	$2,439,708	37,293	-5.4%	Shares	Other	2025-11-14
2025-06-30	$1,557,602	39,423	+4.4%	Shares	Other	2025-08-14
2025-03-31	$1,139,581	37,772	+142.2%	Shares	Other	2025-05-15
2024-12-31	$545,201	15,595	+192.0%	Shares	Other	2025-02-14
2022-09-30	$236,232	5,341	-28.1%	Shares	Other	2022-11-14
2022-06-30	$274,984	7,428	+4321.4%	Shares	Other	2022-08-24
2020-09-30	$7,971	168	-88.1%	Shares	Other	2020-11-16
2020-06-30	$83,369	1,414	—	Shares	Other	2020-08-14
No filing history on record for this holder in this stock.